Introduction {#s1}
============

It is well known that the oxidative stress is involved in a lot of diseases like tumors [@pone.0069351-Gerald1], Alzheimer disease [@pone.0069351-Smith1], aging [@pone.0069351-Balaban1], arthritis [@pone.0069351-Tak1], neurodegenerative disease [@pone.0069351-Lin1] and atherosclerosis [@pone.0069351-Harrison1]. The unbalance between oxidation and antioxidation is the mechanism of oxidative stress [@pone.0069351-Valko1]. *In vivo*, major antioxidases include superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT) and thioredoxin system [@pone.0069351-Valko1], [@pone.0069351-Fukai1].

There are three subtypes of SOD in humans, Cu, Zn-SOD (SOD1), Mn-SOD (SOD2), and extra cellular SOD (SOD3) [@pone.0069351-Mates1]. SOD2 is a mitochondrial manganese (Mn) containing enzyme, which is composed of a 96 kDa homotetramer and localized in the mitochondrial matrix [@pone.0069351-Fridovich1]. Mn at the active site of SOD2 serves to catalyze the disproportionation of superoxide anion to oxygen and H~2~O~2~ in a similar fashion as SOD1 and SOD3 [@pone.0069351-Hsu1]. SOD2 was reported to be one of the antioxidases that have anti-tumor effect [@pone.0069351-Behrend1]. Studies have shown that nuclear factor κB (NF-κB) and activator protein (AP-1) can promote *sod2* expression transcriptionally [@pone.0069351-Kim1]. SIRT3 is a deacetylase located in mitochondria, and a few studies showed that SIRT3 could deacetylate two critical lysine residues on SOD2 and promote its antioxidative activity [@pone.0069351-Qiu1], [@pone.0069351-Kong1]. But up to now, there have rare reports about the post transcriptional regulation of *sod2* gene expression.

MicroRNAs (miRNAs) are evolutionarily conserved 21nt-25nt (nucleotide) small non-coding RNAs. They bind to partially complementary target sites in messenger RNA (mRNA) 3′-untranslated regions (3′-UTRs), which results in degradation of the target mRNA, or translational repression of the encoded protein [@pone.0069351-Bartel1]. It has been estimated that approximately 60% of all mRNA are under the control of miRNA [@pone.0069351-Chan1]. MiRNAs play a significant role in various cellular processes including development, differentiation, cell growth, morphogenesis, apoptosis, and neurological disorders [@pone.0069351-Ambros1], [@pone.0069351-Mendell1]. MiR-146a is widely expressed in different species and tissues, and studies have shown that miR-146a was involved in immunity, inflammation and viral infections by regulating different target genes [@pone.0069351-Li1]. Lukiw et al., showed that miR-146a was significantly up-regulated in interleukin-1β, Aβ42-, and/or oxidatively-stressed human neural (HN) cells in primary culture, and a consequence of miR-146a up-regulation was the down-regulation of the important immune system regulator complement factor H (CFH) [@pone.0069351-Lukiw1]. Another study shows that miR-146a was up-regulated significantly by ROS-generating metal sulfates (iron- plus aluminum-sulfate) in human astroglial (HAG) cells [@pone.0069351-Pogue1].

To reveal the possible involvement of miRNAs in the process of SOD2 expression regulation, we performed candidate *sod2*-targeting miRNAs predictions, reporter gene identification of putative complimentary region, gain-of-function and loss-of-function of miRNAs on SOD2 protein under H~2~O~2~ treatment, and identified a novel functional miRNA regulating SOD2 expression via repressing SOD2 protein translation.

Materials and Methods {#s2}
=====================

Cell Culture {#s2a}
------------

Rat PC12 cells and human SH-SY5Y cells (Shanghai Cell Bank, China) were separately cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM) (Sigma, USA), supplemented with 10% calf serum (HyClone, USA), 100 U/ml of penicillin and 100mg/ml of streptomycin, and maintained in a humidified atmosphere of 5% CO~2~ at 37°C. Cells were subcultured every 2--3 days.

H~2~O~2~ Treatment {#s2b}
------------------

The PC12 was seeded to a density of 1×10^5^/ml in 96-well plates, and 24 h later, the cell was treated with 12.5 µM, 25 µM, 50 µM, 100 µM and 200 µM H~2~O~2~ for 6 h, separately.

Viability Assay {#s2c}
---------------

Viability of PC12 cells was measured by using MTT (3-(4, 5-dimethylthiazol-2-yl) 2, 5-diphenyl tetrazolium bromide) assay. Following incubation, the cells was aspirated and washed with the medium, and treated with 0.5 mg/L MTT (Sigma, USA). After 4 h incubation at 37°C, 100 µl DMSO (dimethyl sulfoxide) (Sigma, USA) was added to each well, then the 96-well plates were being shaked for 10 minutes and the absorbance at 590 nm of solubilized MTT formazan products was measured using a microplate reader (BioTek, USA).

Real-time Polymerase Chain Reaction {#s2d}
-----------------------------------

Total RNA was extracted by TRIzol (Invitrogen, USA) according to the standard procedure. The RNA was treated with RNase-free DNase I (Takara, Japan), and subsequently reverse-transcribed with oligo dT and random 6mer primer. The expression of *sod2* mRNA relative to *β-actin* mRNA was determined by SYBR green I real-time quantitative PCR assay. The primer sequences were as follow, *sod2* forward: 5′-GCCTCCCTGACCTGCCTTAC-3′ reverse: 5′-GTGATTGATATGGCCCCCG-3′; *β-actin* forward: 5′-CCCTAAGGCCAACCGTGAA-3′, reverse: 5′-CCAGAGGCATACAGGGACAAC-3. The relative expression of miR-146a to 5sRNA was determined as described previously by Chen [@pone.0069351-Chen1]. The primers were as follow, reverse transcription primer GTCGTATCCAGTGCAGGGTCCGAGGTATTCGCACTGGATACGACAACCCA; miR-146a forward primer: 5′-GCGTGAGAACTGAATTCCA-3′, reverse primer: 5′-GTGCAGGGTCCGAGGT-3′; 5sRNA forward primer: 5′-CAGCCATACCACCCTGAACG-3′, reverse primer: 5′-GGTATCCCAGGTGGTCTCCC-3′.

Recombinant Plasmid Construction and Dual Luciferase Reporter Assay {#s2e}
-------------------------------------------------------------------

The entire *sod2* mRNA 3′-UTR was PCR-amplified utilizing the sense (5′-GCTCTAGATCCGCCAGGCTGTGTGTC-3′) and antisense (5′-GCTCTAGAAGTAATGTGCATGCCTGGGG-3′) primers according to standard procedures and cloned into the *XbaI* site of the pGL3-Promoter plasmid (Promega, USA). Plasmid DNA was subsequently isolated from recombinant colonies and sequenced to ensure the authenticity and direction of the inserted *sod2* 3′UTR. For the luciferase reporter assays, PC12 cells were grown in DMEM with 10% FBS to 70% confluence in 48-well plates. Cells were transfected with 100 ng of firefly luciferase reporter vector containing the *sod2* 3′UTR (named pGL3-sod2-3′UTR) and miR-146a mimics (Genepharma, China) (final concentration was 100 nM) or negative control using lipofectamine 2000 (Invitrogen, USA). 10 ng pRL-TK vector (Promega, USA) was co-transfected as internal control for normalization of the transfection efficiency. After 24 hours, transfected cells were harvested with ice-cold phosphate-buffered saline, and dual luciferase assay was performed according to the manufacturer's protocol (Promega, USA).

MiRNA Transfection {#s2f}
------------------

miR-146a (rno-miR-146a and hsa-miR-146a share the same sequence) was synthesized by GenePharma company (China). For functional analysis, miR-146a (miR-146a) mimics, antisense miR-146a mimics, non-targeting miRNA mimics (negative control), and scrambled antisense miR-146a (antisense miRNA negative control) were transfected into PC12 and SH-SY5Y cells with lipofectamine according to the manufacturer's instruction, separately. The final concentration of miR-146a mimics and non-targeting miRNA mimics was 100 nM, while the concentration of antisense miR-146a and antisense miRNA negative control was 33 nM. Cells were incubated for 48 h until lysis.

Western Blot {#s2g}
------------

After washing with cold PBS 3 times, cells were lysed in RIPA buffer of 150 mM NaCl, 10mM Tris-HCl, pH 7.4, 0.5% Triton X-100, and protease inhibitors (Sigma, USA), homogenized on ice, and centrifuged at 12,000 g at 4°C for 15 min. The supernatant was collected and stored at −80°C until use. Protein concentration was determined using the BCA Protein Assay Kit (Pierce, USA). 25 µg of protein extraction was loaded on 12% tris-polyacrylamide gels. The proteins were then transferred to nitrocellulose membrane (Milipore, USA). The membranes were blocked in 5% non-fat dry milk, washed in TBS with 0.05% Tween 20 (TBST), and incubated with mouse anti-SOD2 (Santa cruze, USA) in room temperature overnight at 4°C. Mouse anti-β-actin (Santa cruze, USA) was used for internal control. The membranes were washed three times in TBST and incubated for 1 hour with secondary antibodies conjugated to horseradish peroxidase, washed three times in TBST, and treated with Immun-Star HRP peroxide buffer and Luminol/Enhancer (Zhongshan, China) for chemiluminescence detection of protein bands.

Statistical Analysis {#s2h}
--------------------

Statistical analysis was done with one way ANOVA. Differences with *P*\<0.05 were considered statistically significant.

Results {#s3}
=======

H~2~O~2~ Decreased the Survival Rate of PC12 Cells {#s3a}
--------------------------------------------------

To investigate the survival rate changes of PC12 cells under the stimulation of H~2~O~2~, we treated the PC12 cells with different concentrations of H~2~O~2~ for 6 h. The results indicated that low concentrations of H~2~O~2~ (12.5 µM-25 µM) have no obvious effect on PC12 viability. While, with the increase of H~2~O~2~ concentrations, the viabilities of PC12 cells were gradually decreased significantly. ([Fig. 1](#pone-0069351-g001){ref-type="fig"}) Significant viability decrease was observed at 100 µM and 200 µM.

![H~2~O~2~ decreased PC12 cells viability.\
MTT assay showed that 12.5∼25 µM H~2~O~2~ treatment had no obvious effect, while 50 µM, 100 µM, and 200 µM H~2~O~2~ treatment resulted in cell viability decrease by 7%, 15% and 16%, respectively. When compared with control group (0 µM), 100 µM and 200 µM group showed significant difference. Data are shown mean ± SD (n = 6). \**P*\<0.05, as compared with control.](pone.0069351.g001){#pone-0069351-g001}

H~2~O~2~ Regulated the Expression of SOD2 Protein {#s3b}
-------------------------------------------------

Our results demonstrated that, after 6 h treatment, low concentration (12.5 µM) of H~2~O~2~ could result in a relative high level of SOD2 protein. Evidently, the SOD2 protein levels were decreased gradually along with the elevation of H~2~O~2~ concentrations, and the SOD2 level in 200 µM was lower than the control group ([Fig. 2A and 2B](#pone-0069351-g002){ref-type="fig"}). Interestingly, there were no differences of *sod2* mRNA levels between each of the H~2~O~2~-treated groups ([Fig. 2C](#pone-0069351-g002){ref-type="fig"}).

![H~2~O~2~ down-regulated the expression level of SOD2 protein in a dose-dependent manner.\
(A) Along with the increase of H~2~O~2~ concentrations, the SOD2 protein was decreased gradually. Interestingly, the SOD2 protein showed an evident higher level with 12.5 µM and 25 µM H~2~O~2~ stimulation. With the higher concentration 200 µM H~2~O~2~ stimulation, it decreased significantly with a lower level than control group. (B) The relative amounts of SOD2, which were represented by the intensity ratio between SOD2 and β-actin in each lane. Data are shown mean ± SD from 3 independent experiments, each with 6 replicates. (C) H~2~O~2~ had no obvious effect on *sod2* mRNA expression in PC12 cells. After 6 h treatment with different concentrations of H~2~O~2~, the RT-PCR assay demonstrated there were no statistical differences of PC12 *sod2* mRNA expression levels between the groups. Data are shown the mean ± SD (n = 6). ANOVA (Dunnett) \**P*\<0.05, as compared with control.](pone.0069351.g002){#pone-0069351-g002}

MiR-146a Interacted with the 3′UTR of *sod2* mRNA {#s3c}
-------------------------------------------------

With bioinformatics sequence analysis, we found a binding site of miR-146a seed region both in Rattus norvegicus and Homo sapiens *sod2* mRNA 3′UTR ([Fig. 3A](#pone-0069351-g003){ref-type="fig"}). To investigate whether miR-146a interacts with rat *sod2* mRNA 3′UTR *in vitro*, we inserted the whole length region of rat *sod2* mRNA 3′UTR into pGL3-promoter luciferase reporter plasmid 3′UTR region. The reporter constructs were co-transfected with miR-146a mimics in PC12 cells, and the results demonstrated that miR-146a mimics could down regulate the luciferase activity by 29.7% versus negative control group ([Fig. 3B](#pone-0069351-g003){ref-type="fig"}).

![*SOD2* was identified as a target of miR-146a in PC12 and SH-SY5Y cells.\
(A) Prediction of the interaction between *sod2* mRNA 3′UTR and miR-146a. Sequence analysis showed that rat *sod2* mRNA 3′UTR 388-394 position mated with the rat miR-146a 2-8th nucleotides. (B) miR-146a down-regulated the luciferase activity of pGL3-Promoter-sod2-3′UTR. Dual luciferase reporter assay demonstrated that miR-146a mimics could down-regulate relative luciferase activity of pGL-sod2-3′UTR for 29.7%, compared with control group. Data are shown the mean ± SD (n = 6). \*\**P*\<0.01, as compared with control. (C) miR-146a down-regulated the expression of SOD2 protein, while antisense-miR-146a reversely increased the amount of SOD2 protein. NC, non-targeting scrambled-miRNA control. Anti-miR-C, scrambled antisense miRNA control. Anti-miR-146a, antisense-miR-146a. (D) The relative amounts of SOD2 protein treated with miR-146a and antisense-miR-146a were presented by the intensity ratio between SOD2 and β*-*actin in each lane. Data are shown the mean ± SD from 3 independent experiments, \**P*\<0.05.](pone.0069351.g003){#pone-0069351-g003}

MiR-146a Decreased SOD2 Expression {#s3d}
----------------------------------

To investigate whether miR-146a participates in the regulation of SOD2 expression, we transfected miR-146a mimics or non-targeting miRNA mimics into PC12 and SH-SY5Y cells for 48 h, separately. Meanwhile, the antisense miR-146a mimics were transfected for the blockage of the internally originated miR-146a. The western blot assay showed that miR-146a mimics decreased the SOD2 protein expression significantly, while antisense miR-146a mimics up-regulated the SOD2 protein slightly, when compared with non-targeting scrambled-miRNAs and scrambled antisense miR-146a groups, respectively. Taken together, these results showed that miR-146a could regulate the SOD2 expression, and *sod2* was a target gene of miR-146a. ([Fig. 3C and 3D](#pone-0069351-g003){ref-type="fig"}). Also, these results in Homo sapiens cells as well as in Rattus norvegicus cells revealed the novel possible anti-oxidative role of miR-146a.

H~2~O~2~ Induced miR-146a Expression in PC12 Cells {#s3e}
--------------------------------------------------

As shown in [Fig. 4A](#pone-0069351-g004){ref-type="fig"}, miR-146a was up-regulated in a dose-dependent manner by H~2~O~2~ in PC12, which was inversely correlated with the SOD2 expression under H~2~O~2~ treatment. These results indicated the involvement of miR-146a in SOD2 protein expression regulation with H~2~O~2~ stimulation.

![Identification of the regulatory role of miR-146a in the H~2~O~2~ induced changes of SOD2 protein and PC12 cells viability.\
(A) H~2~O~2~ increased the miR-146a expression in PC12 cells. Real-time RT-PCR revealed that H~2~O~2~ enhanced the miR-146a relative expression level in a dose-dependent manner in PC12 cells after the stimulation with H~2~O~2~ for 6 h. Data are shown the mean ± SD (n = 6), \*\**P*\<0.01, as compared with control. (B) Down-regulation of SOD2 was reversed by antisense-miR-146a. PC12 cells were stimulated with 200 µM H~2~O~2~ after a pretreatment with antisense-miR-146a for 24 h. Western blot assay showed antisense-miR-146a reversed the SOD2 protein decrease induced by H~2~O~2~. (C) The relative amounts of SOD2 protein are presented by the intensity ratio between SOD2 and β-actin in each lane. Data are shown the mean ± SD from 3 independent experiments, \**P*\<0.05. (D) Antisense-miR-146a retrieved the decrease of PC12 cells viability induced by 200 µM H~2~O~2~. Data are shown the mean ± SD (n = 6), \**P*\<0.05.](pone.0069351.g004){#pone-0069351-g004}

Antisense-miR-146a Reversed the Decreased SOD2 Expression and PC12 Cells Viability {#s3f}
----------------------------------------------------------------------------------

To verify whether the decrease of miR-146a possesses an effect on SOD2 expression and cell viability with H~2~O~2~ treatment, we pretreated PC12 cells with antisense-miR-146a mimics for 24 h, and then stimulated with 200 µM H~2~O~2~ for 6 h. The results demonstrated that antisense-miR-146a mimics pretreatment could reverse the down-regulated SOD2 expression ([Fig. 4B and 4C](#pone-0069351-g004){ref-type="fig"}) and decreased cell viability ([Fig. 4D](#pone-0069351-g004){ref-type="fig"}) by H~2~O~2~ in PC12 cells.

Discussion {#s4}
==========

Our results indicate that high concentration of H~2~O~2~ causes cell viability decrease in PC12 cells, which is in accord with the previous study by Wei [@pone.0069351-Wei1]. SOD2 plays an important role in maintenance of cell survival under stress conditions, and a lot of studies confirmed that cell viability decrease was correlated with SOD2 down-regulation under stress conditions [@pone.0069351-VanRemmen1], [@pone.0069351-Sharma1]. Meanwhile, when introduced exogenous SOD2 into cell the viability decrease could be improved more or less [@pone.0069351-Plymate1], [@pone.0069351-Fukui1]. To date, the efforts to decipher the mechanism of *Sod*2 gene expression are mainly focused on transcription and post-translational modification. Nevertheless, the post-transcriptional regulatory processes of *Sod*2 expression were seldom explored. Importantly, this regulatory process has been increasingly identified significant and necessary in the process of gene regulation, such as miRNAs down-regulation mechanism. Our studies demonstrate that H~2~O~2~ could significantly alter the SOD2 protein expression. Intriguingly, there are no differences of *sod2* mRNA levels between H~2~O~2~-treated group and control group. These results indicate that the variation of SOD2 protein under H~2~O~2~ treatment is mainly caused in SOD2 protein repression process other than mRNA degradation.

MiRNAs are a class of non-coding RNA, and recent years it has been proved that they play a pivotal role in gene expression regulation. MiR-146a is a widely expressed miRNAs in animal, and recently it has been confirmed to be involved in immunity, inflammation, viral infections, etc. [@pone.0069351-Li1]. With the bioinformatics tools, including RegRNA and Miranda, Dharap found that SOD2 was possibly a target of miR-145. After transient middle cerebral artery occlusion (MCAO), the rat post-ischemic brain showed highly expressed miR-145. Meanwhile, miR-145 inhibitor pretreatment could induce SOD2 expression in reperfusion brain, indicating that elevated miR-145 could depress the SOD2 expression in MCAO brain [@pone.0069351-Dharap1]. In addition, a study using luciferase reporter assay revealed that miR-222 could bind the *sod*2 3′UTR, and the expression of SOD2 was reduced in a carcinoma cells when transfected with ectopic miR-222 [@pone.0069351-Liu1]. Also, Kriegel and colleagues demonstrated that treatment of human renal epithelial cells with TGF-β1 resulted in up-regulation of miR-382 and down-regulation of SOD2. In this study, knockdown of miR-382 could attenuate TGF-β1 induced down-regulation of SOD2 protein, and 3′UTR reporter assay showed miR-382 could target *sod*2 mRNA [@pone.0069351-Kriegel1]. Taken together, these results suggest that miR-382, miR-145 and miR-222 can regulate the expression of SOD2 in different pathological processes.

In our study, the results of reporter assay indicate the interaction between miR-146a and *sod*2 3′UTR, and both the gain-of-function and loss-of-function experiments demonstrate that miR-146a could regulate the expression of SOD2. Furthermore, we confirm that miR-146a is up-regulated by H~2~O~2~, and H~2~O~2~-caused cell viability decrease can be reversed by antisense-miR-146a. These results identify the post-transcriptional regulatory role of miR-146a in SOD2 expression, indicating the possible involvement of miR-146a in oxidative stress.

In conclusion, this study demonstrates that *Sod2* expression can be regulated by miR-146a, and identifies a novel function of miR-146a in *sod*2 expression via inhibiting protein translation.
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